Skip to content
OpenCapital
Get started

Innovate VATE Life Sciences — Total Revenue

Other segment segments

Infrastructure
$373.9M+65.7%
Spectrum
$5.7M-16.2%

Other financials

Income statement

See full
Revenue$364.8M+33.0%
Gross profit$53.5M+17.6%
Operating income$10.0M+194%
Net income-$16.8M+31.4%
EPS (diluted)-$1.29+31.7%

Balance sheet

See full
Cash & equivalents$134.6M+297%
Total debt$1.4B+11.6%
Total equity-$256.3M-25.5%
Total assets$936.8M+7.9%

Cash flow

See full
Operating cash flow$45.5M+423%
CapEx$200.0K-95.7%
Free cash flow$45.3M+341%

Valuation

See full
Market cap$254.69M+274%

Where this comes from

Reported directly by Innovate in its filing.

Tagged under the XBRL concept us-gaap:Revenues.

The official record: Innovate’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Innovate's life sciences — total revenue.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Innovate's life sciences — total revenue?
Innovate (VATE) reported life sciences — total revenue of $1.6M in Q1 2026.
How has Innovate's life sciences — total revenue changed year-over-year?
Innovate's life sciences — total revenue decreased by 48.4% year-over-year, from $3.1M to $1.6M.
What is the long-term trend for Innovate's life sciences — total revenue?
Over 2 years (2023 to 2025), Innovate's life sciences — total revenue has grown at a 94.6% compound annual growth rate (CAGR), from $3.3M to $12.5M.
What does life sciences — total revenue mean?
This metric represents the total gross income generated by the Life Sciences business segment from its primary operations. It reflects the segment's market demand and ability to monetize its products or services within the life sciences industry.